• Exchange: Tokyo
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Shin Nippon Biomedical Laboratories Ltd

+ Add to Watchlist

2395:JP

912.0 JPY 22.0 2.36%

As of 02:00:00 ET on 09/19/2014.

Snapshot for Shin Nippon Biomedical Laboratories Ltd (2395)

Open: 925.0 Day's Range: 897.0 - 928.0 Volume: 896,400
Previous Close: 934.0 52wk Range: 658.0 - 1,786.0 1-Yr Rtn: -32.44%

Stock Chart for 2395

No chart data available.
  • 2395:JP 914.0
  • 1D
  • 1M
  • 1Y
934.0
Interactive 2395 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2395

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) -
Relative P/E vs. TPX -
Earnings Per Share (JPY) (ttm) -28.5800
Est. EPS (JPY) (03/2015) -15.1000
Est. PEG Ratio -
Market Cap (M JPY) 36,275.71
Shares Outstanding (M) 39.78
30 Day Average Volume 845,513
Price/Book (mrq) 3.7416
Price/Sale (ttm) 2.0684
Dividend Indicated Gross Yield -%
Cash Dividend (JPY) -
Dividend Ex-Date 03/27/2014
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2395

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 2395

Shin Nippon Biomedical Laboratories Ltd is a contract research organization. The Company provides pre-clinical testing services in the pharmaceutical industry.

Ryoichi NagataChairman/President/CEOToshihiko SekiExecutive Vice President
Koichiro FukuzakiExecutive Vice PresidentKen TakanashiSenior Managing Director
More Company Profile & Key Executives for 2395

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil